Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Variations in the latitudinal diversity gradients of the ocean microbiome.

Cell host & microbe·2026
Same author

microntology: a lightweight, data-driven controlled vocabulary to describe earth's microbial habitats.

Bioinformatics (Oxford, England)·2026
Same author

Molecular maps of diseases from omics data and network embeddings.

NPJ systems biology and applications·2026
Same author

CCMRI: a classification and curated database of climate change-related microbiome studies.

Scientific reports·2026
Same author

Estimating the economic burden of lower respiratory infections in China from 2020 to 2040: a health-augmented macroeconomic modelling study.

The Lancet regional health. Western Pacific·2026
Same author

Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism.

JHEP reports : innovation in hepatology·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jul 3, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Identificación de la droga objetivo utilizando la similitud de efectos secundarios.

Monica Campillos1, Michael Kuhn, Anne-Claude Gavin

  • 1European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, 69117 Heidelberg, Germany.

Science (New York, N.Y.)
|July 16, 2008
PubMed
Resumen
Este resumen es generado por máquina.

Este estudio revela que los efectos secundarios de los medicamentos pueden predecir objetivos de drogas compartidos, incluso para medicamentos químicamente diferentes. Este enfoque identifica nuevas interacciones fármaco-objetivo y posibles nuevos usos terapéuticos para los medicamentos existentes.

Más Videos Relacionados

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Videos de Experimentos Relacionados

Last Updated: Jul 3, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Área de la Ciencia:

  • Farmacología Farmacología.
  • Biología computacional Biología computacional.
  • Descubrimiento de Drogas Descubrimiento de Drogas

Sus antecedentes:

  • La predicción tradicional de objetivos farmacológicos se basa en características moleculares o celulares como la estructura química o la actividad de las líneas celulares.
  • La identificación de objetivos de drogas compartidos es crucial para comprender los mecanismos de las drogas y reutilizar los medicamentos.

Objetivo del estudio:

  • Investigar la utilidad de las similitudes fenotípicas de efectos secundarios para inferir objetivos de drogas compartidos.
  • Descubrir nuevas relaciones entre fármacos y posibles interacciones entre fármacos utilizando un análisis a gran escala de los medicamentos comercializados.

Principales métodos:

  • Utilizó similitudes fenotípicas de efectos secundarios en 746 fármacos comercializados para construir una red de relación entre fármacos.
  • Validación experimental de las predicciones de las relaciones fármaco-fármaco e interacciones implícitas fármaco-objetivo utilizando ensayos de unión in vitro y basados en células.

Principales resultados:

  • Identificó una red de 1018 relaciones entre fármacos basadas en efectos secundarios, incluidas 261 que involucran fármacos químicamente diferentes en diferentes áreas terapéuticas.
  • Experimentalmente se validaron 13 relaciones implícitas de fármaco-objetivo, de las cuales 11 mostraron constantes de inhibición por debajo de 10 micromolares.
  • Confirmó nueve de estas interacciones en ensayos basados en células, lo que demuestra la viabilidad del enfoque fenotípico.

Conclusiones:

  • La similitud fenotípica de efectos secundarios es una estrategia viable para inferir interacciones moleculares y objetivos de fármacos compartidos.
  • Este método identificó con éxito relaciones inesperadas entre fármacos y validó nuevas interacciones entre fármacos.
  • Los hallazgos sugieren posibles nuevas aplicaciones terapéuticas para los medicamentos comercializados existentes.